YOUNG KEVIN 4
4 · GILEAD SCIENCES INC · Filed Feb 23, 2018
Insider Transaction Report
Form 4
YOUNG KEVIN
EVP, Commercial Operations
Transactions
- Award
Common Stock
2018-02-15$62.35/sh+340$21,198→ 16,152 total - Award
Common Stock
2018-02-21+9,460→ 25,612 total
Footnotes (2)
- [F1]Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
- [F2]Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 2, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual satisfies the applicable service-vesting requirements by continuing in the Issuer's employ through December 31, 2018 and December 31, 2019, respectively.